Related Experiment Video
Updated: Jun 19, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Gateways to clinical trials
1Prous Science, S.A.U., Barcelona, Spain. ts.serviceprous.es@thomson.com
Methods and Findings in Experimental and Clinical Pharmacology
|October 3, 2009
Summary
This study reviews a comprehensive list of pharmaceutical agents, including novel therapeutics and established drugs, for various medical conditions. It provides a valuable resource for researchers and clinicians seeking information on drug development and therapeutic applications.
Area of Science:
- Pharmacology
- Drug Discovery
- Medicinal Chemistry
Context:
- The landscape of pharmaceutical development is rapidly evolving, with numerous novel agents and established drugs under investigation.
- Understanding the therapeutic potential and applications of these diverse compounds is crucial for advancing medical science.
- This abstract compiles a broad spectrum of pharmaceutical agents, encompassing small molecules, biologics, and radiopharmaceuticals.
Purpose:
- To present a curated list of pharmaceutical agents for a wide range of therapeutic areas.
- To serve as a reference for researchers, clinicians, and drug developers.
- To highlight the diversity of chemical structures and therapeutic modalities in current pharmaceutical research.
Summary:
- The abstract lists over 100 pharmaceutical agents, including [90Y-DOTA-Tyr3]octreotate, Abatacept, Adefovir dipivoxil, Aripiprazole, Bevacizumab, Bortezomib, Cetuximab, Dabigatran etexilate, Darunavir, Doripenem, Duloxetine hydrochloride, Escitalopram oxalate, Exenatide, Ezetimibe, Fondaparinux sodium, Gabapentin enacarbil, Golimumab, Liraglutide, Lopinavir/ritonavir, Omalizumab, Paclitaxel nanoparticles, Pazopanib hydrochloride, Peginterferon alfa-2a, Pemetrexed disodium, Pregabalin, Ranibizumab, Regadenoson, Rilonacept, Saxagliptin, Sorafenib, Tadalafil, Tenofovir disoproxil fumarate/emtricitabine, Tolvaptan, Vardenafil hydrochloride hydrate, and Vorinostat.
- This compilation spans various therapeutic classes, including oncology, immunology, infectious diseases, cardiovascular conditions, and central nervous system disorders.
- The list includes both small molecule drugs and biologic agents, reflecting the breadth of modern pharmaceutical research.
Impact:
- Provides a valuable resource for identifying potential drug candidates and therapeutic strategies.
- Facilitates interdisciplinary research by consolidating information on diverse pharmaceutical agents.
- Supports the advancement of drug discovery and development pipelines across multiple medical fields.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...